Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Sites

Sites

Member institutions and other sites of the Early Detection Research Network.

Biomarker Developmental Laboratories

Sites With No Associated Organ

(No Proposal)
Investigator Site
Boston University
Biomarker Detection Using NAPPA Tumor Antigen Arrays
Investigator Site
Arizona State University

Breast and Ovarian

An Integrated Systems Biology Approach for Ovarian Cancer Biomarker Discovery
Investigator Site
Mount Sinai Hospital
Biomarker Detection Using NAPPA Tumor Antigen Arrays
Investigator Site
Arizona State University
MiRNAs/UCRs: Biomarkers for Cancer Risk, Tumor Detection, Progression and Treatment
Investigator Site
The Ohio State University Medical Center
Proteomic, Genetic and Longitudinal Pathways to Ovarian Cancer Biomarker Discovery
Investigator Site
Massachusetts General Hospital
Dana Farber Cancer Institute/Harvard Medical School
Massachusetts General Hospital

Colorectal

Affinity Based Strategies to Fast Track Development of Colon Cancer Biomarkers
Investigator Site
The University of Texas MD Anderson Cancer Center
Fred Hutchinson Cancer Research Center
Identify and Validate Novel Epigenetic Molecular Markers for Colorectal Neoplasm
Investigator Site
Fred Hutchinson Cancer Research Center
Case Western Reserve University
Refinement and Discovery of Nuclear Matrix Protein Markers for Colorectal Cancer
Investigator Site
University of Pittsburgh Cancer Institute
Spectral Markers for Early Detection of Colon Neoplasia
Investigator Site
NorthShore University HealthSystem
Northwestern University
Vanderbilt Biomarker Developmental Laboratory
Investigator Site
Vanderbilt Medical Center
Vanderbilt Medical Center

Lung

Integrated Development of Novel Molecular Markers
Investigator Site
Johns Hopkins University School of Medicine
MiRNAs/UCRs: Biomarkers for Cancer Risk, Tumor Detection, Progression and Treatment
Investigator Site
The Ohio State University Medical Center
Vanderbilt Biomarker Developmental Laboratory
Investigator Site
Vanderbilt Medical Center
Vanderbilt Medical Center

Prostate

A Systems Biology Approach to the Development of Cancer Biomarkers
Investigator Site
University of Michigan
Weill Cornell Medical College
Glycoprotein Biomarkers for the Early Detection of Aggressive Prostate Cancer
Investigator Site
Johns Hopkins University School of Medicine
New Tools for Prostate Cancer Detection and Prognostication
Investigator Site
Stanford University Medical Center
Stanford University
The Early Detection Research Network: Biomarker Developmental Laboratory
Investigator Site
University of Washington
The Prostate Cancer Tumor Microenvironment Exhibits Differentially Expressed Genes
Investigator Site
University of California, Irvine
Northwestern University, Feinberg School of Medicine

Biomarker Reference Laboratories

Clinical Validation Centers

Data Management and Coordinating Center

Informatics Center

National Cancer Institute

Associate Members

This section lists associate EDRN members.

Associate Member A — EDRN Funded

Associate Member B

Site Investigator
AIBioTech
Baylor College of Medicine
Beth Israel Deaconess Medical Center
Biosite Incorporated
Biosystems International SAS
Brigham and Women's Hospital
Brigham and Women's Hospital
British Columbia Cancer Agency
British Columbia Cancer Research Centre/Cancer Genetics and Development Biology
Burlington Urology
CURC/Carolina Urologic Research Center
Cangen Biotechnologies, Inc.
Case Western Reserve University
Center for Asbestos Related Diseases
Columbia University Medical Center
Dana Farber Cancer Institute-BWH
Eastern Virginia Medical School
Eastern Virginia Medical School
Exact Sciences
Fox Chase Cancer Center
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Geisinger Health System
Gesinger Health System
Harborview Medical Center
Hologic Gen-Probe Incorporated
INOVA Diagnostics, Inc.
Instituto Valenciano de Infertilidad
Johns Hopkins Medical Institute
Johns Hopkins University
Johns Hopkins University
Johns Hopkins University
Johns Hopkins University Department of Urology
Kalloger Consulting
LURN-Daytona Beach
LURN-New Jersey
LURN-Orange City
LabCorp Molecular Biology & Pathology
Mayo Clinic
Mayo Clinic
Mayo Clinic Jacksonville
Mayo Clinic-Jacksonville
Medical College of Georgia
Memorial Sloan-Kettering
Memorial Sloan-Kettering Cancer Center
Moffitt Cancer Center
Mount Sinai Hospital
Mount Sinai Medical Center
Mt. Sinai Medical Center
Mt. Sinai Medical Center
National Cancer Institute
National Cancer Institute at Frederick
National Cancer Institute-PLCO
New York University
NorthShore University HealthSystem
Pacific Northwest National Laboratory
Saint Louis University
San Diego Clinical Trials
Source MDx
St. Michael's Hospital
Stanford University
Stanford University
Stanford University
The Fe/Male Health Clinic
The Johns Hopkins University
The Male Health Centre
The Male/Female Health and Research Center
The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
The Urology Group
Thomas Jefferson University
UT Southwestern Medical Center
UT Southwestern Medical Center at Dallas
Univ of Michigan
University of Alabama
University of Alabama at Birmingham
University of British Columbia
University of California, Los Angeles
University of California, San Francisco
University of Chicago Urology Center
University of Illinois at Chicago
University of Kansas Medical Center
University of Michigan
University of Michigan
University of Michigan
University of Michigan
University of Michigan
University of Michigan
University of Michigan
University of Michigan
University of Minnesota
University of Nebraska
University of Nebraska Medical Center
University of North Carolina
University of Pennsylvania
University of Rochester Medical Center
University of Southern California/Norris Cancer Center
University of Texas Health Science Center San Antonio
University of Toronto
University of Washington
University of Washington
University of Western Australia
University of York
Urotec
VA Medical Center Seattle
Vanderbilt University
Vejle Hospital
Wako Diagnostics
Wistar

Associate Member C

Site Investigator
Abbott
Abbott Laboratories
AmberGen, Inc.
Ambergen, Inc.
Arizona Cancer Center
Arizona State University
Baylor
Beckman Coulter
Beckman Coulter
Beckman Research Institute of the City of Hope
Beth Israel Deaconess Medical Center
Bio-Rad
Biochain
Brigham and Women's Hospital
Brigham and Women's Hospital
Brighton Consulting Group
CRUK Cambridge Research Institute
Centers for Disease Control
Commonwealth Scientific & Industrial Research Organisation
Creighton University
Drexel University College of Medicine
Drexel University College of Medicine
Duke University
Duke University Medical Center
Eastern Virginia Medical School
Emory University
Fox Chase Cancer Center
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Genetica, Inc.
Genteomics USA, Inc.
Genteomics USA, Inc.
GlaxoSmithKline
H. Lee Moffitt Cancer Center
H. Lee Moffitt Cancer Center
Iceland Genomics Corporation
Indiana University
Insightful, Inc.
Institute of Cancer Research
Instituto Nazionale Tumori Regina Elena
Johns Hopkins Medical Institutions
Johns Hopkins School of Medicine
Johns Hopkins University
Johns Hopkins University
Johns Hopkins University
Johns Hopkins University
Karmanos Cancer Institute
Lombardi Comprehensive Cancer Center
Lombardi Comprehensive Cancer Center
Lovelace Respiratory Research Institute
MD Anderson Cancer Center
MDxHealth, Inc.
Medical University of South Carolina
Medical University of South Carolina
Meharry Medical College School of Medicine
Meso Scale Diagnostics
Metabolon
Metabolon, Inc.
Milagen, Inc.
Mitchell Cancer Institute
Mitchell Cancer Institute
Mitchell Cancer Institute
Mount Sinai Medical Center
NOX Technologies
NanoInk, Inc.
National Cancer Institute
National Cancer Institute Tumor Glycome Laboratory
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Standards and Technology
National Institute of Standards and Technology
NextGen Sciences
Nidaan, Inc.
Northwestern University, Feinberg School of Medicine
Pacific Nanoscience, Inc.
Pacific Northwest National Laboratory
Peter MacCAllum Cancer Institute
PrimeraDx
Private Consultant
Quanterix
Rheinische Friedrich-Wilhelms-Universitat
Roche Diagnostics
Sage Bionetworks
Samsung Medical Center
Sanford-Burnham Medical Research Institute
SomaLogic
Stanford University
Stanford University
The Ohio State University
The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
The University of Texas MD Anderson Cancer Center
Transgenomic, Inc.
UT Health Science Center San Antonio
UT Southwestern Medical Center
UT Southwestern Medical Center
University of Alabama at Birmingham
University of California at San Francisco
University of California, Davis
University of California, Los Angeles
University of California, Los Angeles
University of California, San Diego
University of California, San Francisco
University of Colorado Health Science Center
University of Copenhagen/Hvidovre Hospital
University of Georgia
University of Maryland
University of Maryland, Baltimore
University of Michigan
University of Michigan
University of Michigan Medical Center
University of Michigan Medical School
University of Michigan Medical School
University of Michigan Medical School
University of New Mexico
University of North Carolina at Chapel Hill
University of Pittsburgh Cancer Instititute
University of Pittsburgh Cancer Institute
University of Texas at San Antonio
University of Washington
Urological Sciences Research Foundation
VU Medical Center
Ventana
Ventana
Veridex, LLC
Weizmann Institute of Science
Xenomics
Yale University
Yale University School of Medicine
diaDexus
diaDexus

SPOREs

Non-EDRN Sites

This section lists non-EDRN sites.

Non-EDRN Site

Site Investigator
Atrium Medical Center
Boston University School of Medicine
Boston University School of Medicine
Canary Foundation
Carle Cancer Center
Case Comprehensive Cancer Center/Case Western Reserve University
Center of Oncology, Cracow Division
Cleveland Clinic
Clínica Las Condes/Universidad de Chile
Duke University Medical Center
EIC Laboratories, Inc.
Eppley Institute for Cancer Research/University of Nebraska Medical Center
Essentia Health Duluth CCOP
Ewha Womans University, Seoul, Korea
Food and Drug Administration
Forsyth Regional Cancer Center
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Fujirebio Diagnostics, Inc.
Genomic Health, Inc.
Grand Rapids Clinical Oncology Program
Gundersen Lutheran
H. Lee Moffitt Cancer Center and Research Institute
Harvard Medical School
Henry Ford Hospital
IFOM, The FIRC Institute for Molecular Oncology Foundation
Institute of Medical Science, The University of Tokyo
International Prevention Research Institute (iPRI)
Johns Hopkins Medical Institutions
Johns Hopkins University
Lab Corps
Marshfield Clinic
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Mercy Physicians of Oklahoma
Mount Sinai Hospital
NASPCC/Mountain Foundation For Lung Cancer
Nanjing University
Natalie Warren Bryant Cancer Center
National Cancer Institute
National Cancer Institute
National Cancer Institute
New York University School of Medicine
North Eastern University
Novartis
Novartis Institutes for BioMedical Research, Inc.
Orange County Urological Associates
Pacific Northwest National Laboratory (PNNL)
Quest Diagnostics
Research Advocacy Network
Roswell Park Cancer Institute
Rush University Medical Center
SUNY Upstate Medical Hospital
Safety Mutual of the Chilean Chamber of Construction
Sanford Cancer Center Oncology Clinic
Sanford Clinic North-Fargo
Second Military Medical University
Sidney Kimmel Comprehensive Cancer Center/Johns Hopkins University
SomaLogic
St. Vincent CCOP
Temple University
The Ohio State University Comprehensive Cancer Center
The University of Nottingham, UK
Tripler Army Medical Center
University of Arkansas Medical Sciences
University of Bari
University of Colorado School of Medicine
University of Halle-Wittenberg
University of Hawaii MBCCCOP
University of Kentucky
University of Kentucky College of Medicine
University of Michigan
University of North Carolina School of Medicine
University of Southern California Norris Cancer Center
University of Toledo Medical Center
University of Washington
University of Washington School of Medicine
Upstate Carolina CCOP
Vanderbilt University Medical Center
Vanderbilt University School of Medicine
Vanderbilt University School of Medicine
Vanderbilt-Ingram Cancer Center
Wako Diagnostics
Washington University in St. Louis
Weiss Memorial Hospital
Wichita CCOP
William Beaumont Hospital
News

The final report of the 2013 Cancer Biomarkers Bioinformatics Workshop is now available.

Announcement 06/26/2014


Please click here to register for the 9th EDRN Scientific Workshop from September 8-10, 2014, in Bethesda, Maryland. The meeting registration page also has agendas and hotel reservation information.
Announcement 06/05/2014


Funding Opportunity Available

Both RFAs for Molecular and Cellular Characterization of Screen-Detected Lesions have been published.

RFA-CA-14-010.html

and

RFA-CA-14-011.html